Fig. 2. MSCs potentially exert an antidepressant
Fig. 2. MSCs potentially exert an antidepressant effect through 5-HT DRN neurons.
a Schematic diagram showing
a Schematic diagram showing the experimental procedures. b Representative images and quantification showing that 5-HT neurons in the DRN were eliminated by 5, 7-DHT injection. Scale bar, 100m. Two-tailed t test: t=15.43, df = 8, **** P=0.00000031. n=5 mice. 5, 7-DHT, 5,7-Dihydroxytryptamine. c Representative images and quantification showing that 5-HT neurons in the DRN were eliminated by AAV injection to overexpress Caspase3. Scale bar, 100m. Two-tailed t test: t=22.12, df = 8, **** P=0.000000018. n=5 mice. d, f Representative activity tracking in the OFT. e, g Statistical analysis of the total distance, the center distance, and the center time. e Total distance, one-way ANOVA: F(3, 36)=0.9807nsP=0.41. e Center distance, one-way ANOVA: F(3, 36)=7.363 *** P=0.00057. e Center time, one-way ANOVA: F(3, 36)=10.50 **** P=0.000042. g Total distance, Kruskal-Wallis test: ns P=0.46. g Center distance, Kruskal-Wallis test: ** P=0.0043. g Center time, one-way ANOVA: Treatment F(3, 36)=4.097 * P=0.013. n=10 mice. h, k Representative activity tracking in the EPM. i, l Statistical analysis of the time spent in and entry numbers to open arms. (i) Open arms time, Brown-Forsythe ANOVA test: *** P=0.00037. (i) Open arms entry number, one-way ANOVA: F(3, 36)=5.219 ** P=0.0043. l Open arms time, Kruskal-Wallis test: ** P=0.0030. l Open arms entry number, one-way ANOVA: F(3, 36)=5.485 ** P=0.0033. n=10 mice. j, m Statistical analysis of the immobile time in the TST. j Immobile time, one-way ANOVA: F(3, 36)=16.4 **** P=0.00000070. m Immobile time, one-way ANOVA: F(3, 36)=14.25 **** P=0.0000028. n=10 mice. Illustrations created with BioRender.com. Source data are provided as a Source Data file.
More:
Mesenchymal stromal cells alleviate depressive and anxiety-like ...
- Exploring the mechanism of bone marrow mesenchymal stromal cell exosomes in respiratory syncytial virus infection based on miRNA sequencing - Nature - April 23rd, 2025
- Autologous Versus Allogeneic Adipose-Derived Mesenchymal Stem Cell Therapy for Knee Osteoarthritis: A Systematic Review, Pairwise and Network... - April 23rd, 2025
- Exosomes: What They Do and Whos Doing What - geneonline.com - April 23rd, 2025
- Understanding Mesenchymal Stem Cells (MSCs) - Stem Cell Therapy | Miami ... - April 19th, 2025
- Mesenchymal Stem Cell Therapy Market Size Report 2030 - Grand View Research - April 19th, 2025
- A Deep Dive on Mesenchymal Stem Cells - Celltex Therapeutics - April 19th, 2025
- Mesenchymal stromal/stem cells from perinatal sources: biological facts ... - April 15th, 2025
- The mitochondrial unfolded protein response inhibits pluripotency acquisition and mesenchymal-to-epithelial transition in somatic cell reprogramming -... - April 13th, 2025
- BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn in ALS - StreetInsider - April 11th, 2025
- Role of METTL16 in PPAR methylation and osteogenic differentiation - Nature - April 11th, 2025
- PCL scaffold with well-defined hierarchical pores effectively controls cell migration and alignment of human mesenchymal stem cells - Nature - April 4th, 2025
- Circ-ITCH promotes the ubiquitination degradation of HOXC10 to facilitate osteogenic differentiation in disuse osteoporosis through stabilizing BRCA1... - March 28th, 2025
- Injectable bioadhesive and lubricating hydrogel with polyphenol mediated single atom nanozyme for rheumatoid arthritis therapy - Nature.com - March 21st, 2025
- Mesenchymal Stem Cells: Characteristics, Function, and ... - March 17th, 2025
- Nf2-FAK signaling axis is critical for cranial bone ossification and regeneration - Nature.com - March 16th, 2025
- 1. Ultimate Guide: 10 Mesenchymal Stem Cell Research Updates Now - March 14th, 2025
- The Application of Mesenchymal Stem Cell Therapy in Treating ... - Cureus - March 14th, 2025
- Innovative Study Highlights BMP9 and SHH as Key Drivers of Bone Repair - EIN News - March 14th, 2025
- Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 ... - March 11th, 2025
- Mesenchymal stem cells | EBSCO Research Starters - March 11th, 2025
- Ryoncil, the first FDA-approved mesenchymal stromal cell therapy - March 9th, 2025
- Ryoncil, the first FDA-approved mesenchymal stromal cell therapy - Pharmaceutical Technology - March 5th, 2025
- Capsanthin inhibits migration and reduces N-linked glycosylation of PD-L1 via the EZH2-PD-L1 axis in triple-negative breast cancer brain metastasis -... - March 5th, 2025
- sLZIP functions as a key modulator of bone remodeling by regulating the crosstalk between osteoblasts and osteoclasts - Nature.com - March 3rd, 2025
- Bone and muscle crosstalk in ageing and disease - Nature.com - February 27th, 2025
- Eterna Therapeutics Hosts Successful Inaugural Meeting with - GlobeNewswire - February 27th, 2025
- Mesenchymal Stem/Stromal Cells An update | SpringerLink - February 25th, 2025
- Efficacy and safety of mesenchymal stromal cell ... - PubMed - February 17th, 2025
- Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue ... - February 17th, 2025
- Mesenchymal stem cells derived exosomes: a new era in cardiac ... - February 17th, 2025
- Mesenchymal Stem Cell Therapy for Superior Gluteal Nerve ... - Cureus - February 17th, 2025
- Stem cell therapy found to reduce itch, pain in RDEB children in trial - Epidermolysis Bullosa News - February 15th, 2025
- Fate and long-lasting therapeutic effects of mesenchymal stromal/stem ... - February 6th, 2025
- Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2 - Nature.com - January 31st, 2025
- The role of ultrasound combined with water bath in the establishment of animal models of rat urethral stricture - Nature.com - January 25th, 2025
- Why exosome therapy is 2025s It skincare trend - Harpers Bazaar India - January 23rd, 2025
- Identification of glutamine as a potential therapeutic target in dry eye disease - Nature.com - January 23rd, 2025
- Polycystin-1 regulates tendon-derived mesenchymal stem cells fate and matrix organization in heterotopic ossification - Nature.com - January 21st, 2025
- Correction: Adipose-derived mesenchymal stromal cells promote corneal wound healing by accelerating the clearance of neutrophils in cornea -... - January 21st, 2025
- Adipose-Derived Stem Cell Therapy Combined With Platelet-Rich Plasma for the Treatment of Avascular Necrosis of the Talus - Cureus - January 19th, 2025
- Q&A: Mesenchymal stem cells where do they come from and is ... - January 19th, 2025
- An overview of mesenchymal stem cells and their potential ... - January 19th, 2025
- Senescent mesenchymal stem/stromal cells and restoring their cellular ... - January 13th, 2025
- Mesenchymal Stem Cells and Reticulated Platelets: New Horizons in ... - January 13th, 2025
- Mesenchymal Stem Cells/Medicinal Signaling Cells (MSCs) - GlobeNewswire - January 13th, 2025
- A SAGE View of Mesenchymal Stem Cells - PMC - January 13th, 2025
- Mesenchymal stem cell perspective: cell biology to clinical progress - January 3rd, 2025
- Canid alphaherpesvirus 1 infection alters the gene expression and secretome profile of canine adipose-derived mesenchymal stem cells in vitro -... - December 28th, 2024
- MSC-derived exosomal circMYO9B accelerates diabetic wound healing by promoting angiogenesis through the hnRNPU/CBL/KDM1A/VEGFA axis - Nature.com - December 27th, 2024
- Korean researchers prove stem cell therapys effectiveness for hereditary cerebellar ataxia in animal models - KBR - December 25th, 2024
- FDA Approves First MSC Therapy in Steroid-Refractory GVHD - www.oncnursingnews.com/ - December 25th, 2024
- FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid ... - December 22nd, 2024
- FDA Approves Mesenchymal Stromal Cell Therapy for Refractory Acute GVHD in Kids - Medpage Today - December 20th, 2024
- FDA Grants First-Ever Approval for MSC Therapy to Australian Company Mesoblast After Attempting for 4 Years - geneonline - December 20th, 2024
- Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges - Benzinga - December 20th, 2024
- Mesoblast finally pushes GvHD cell therapy over finish line - pharmaphorum - December 20th, 2024
- Mesenchymal stem cells in health and disease - PubMed - December 19th, 2024
- Mesoblast's RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy - The Manila Times - December 19th, 2024
- FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease - PR Newswire - December 19th, 2024
- RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead - MarketWatch - December 17th, 2024
- An injury-induced mesenchymal-epithelial cell niche coordinates regenerative responses in the lung - Science - December 15th, 2024
- New insights into survival of breast cancer cells in the bone marrow - News-Medical.Net - December 9th, 2024
- Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidates (ERNA-101) Ability to Induce and Modulate... - December 7th, 2024
- Enhanced osteogenic potential of iPSC-derived mesenchymal progenitor cells following genome editing of GWAS variants in the RUNX1 gene - Nature.com - December 7th, 2024
- Exploring the potential of MSCs in cancer therapy - News-Medical.Net - December 5th, 2024
- Eterna Therapeutics Partners with MD Anderson to Advance Cancer Cell Therapy Research | ERNA Stock News - StockTitan - December 5th, 2024
- How breast cancer cells survive in bone marrow after remission - Medical Xpress - December 5th, 2024
- A blood glucose fluctuation-responsive delivery system promotes bone regeneration and the repair function of Smpd3-reprogrammed BMSC-derived exosomes... - December 1st, 2024
- Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus ... - December 1st, 2024
- Exploring mesenchymal stem cells homing mechanisms and ... - PubMed - November 26th, 2024
- Macrophage tracking with USPIO imaging and T2 mapping predicts immune rejection of transplanted stem cells - Nature.com - November 26th, 2024
- IL-10RA governor the expression of IDO in the instruction of lymphocyte immunity - Nature.com - November 26th, 2024
- Mesenchymal Stem Cells: Time to Change the Name! - November 26th, 2024
- Researchers have brought the promise of stem cell therapies closer to reality - The Week - November 25th, 2024
- Engineering bone/cartilage organoids: strategy, progress, and application - Nature.com - November 25th, 2024
- Proteomic analysis of human Whartons jelly mesenchymal stem/stromal cells and human amniotic epithelial stem cells: a comparison of therapeutic... - November 20th, 2024
- Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with... - November 20th, 2024
- Mesenchymal stem cells lineage and their role in disease development - November 18th, 2024
- Mesenchymal Stem Cells - SpringerLink - November 18th, 2024
- Exosomes: The Insulin of Our Era? - University of Miami - November 18th, 2024
Recent Comments